These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23126626)

  • 1. Core refinement toward permeable β-secretase (BACE-1) inhibitors with low hERG activity.
    Ginman T; Viklund J; Malmström J; Blid J; Emond R; Forsblom R; Johansson A; Kers A; Lake F; Sehgelmeble F; Sterky KJ; Bergh M; Lindgren A; Johansson P; Jeppsson F; Fälting J; Gravenfors Y; Rahm F
    J Med Chem; 2013 Jun; 56(11):4181-205. PubMed ID: 23126626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides.
    Swahn BM; Kolmodin K; Karlström S; von Berg S; Söderman P; Holenz J; Berg S; Lindström J; Sundström M; Turek D; Kihlström J; Slivo C; Andersson L; Pyring D; Rotticci D; Ohberg L; Kers A; Bogar K; von Kieseritzky F; Bergh M; Olsson LL; Janson J; Eketjäll S; Georgievska B; Jeppsson F; Fälting J
    J Med Chem; 2012 Nov; 55(21):9346-61. PubMed ID: 22924815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.
    Brodney MA; Barreiro G; Ogilvie K; Hajos-Korcsok E; Murray J; Vajdos F; Ambroise C; Christoffersen C; Fisher K; Lanyon L; Liu J; Nolan CE; Withka JM; Borzilleri KA; Efremov I; Oborski CE; Varghese A; O'Neill BT
    J Med Chem; 2012 Nov; 55(21):9224-39. PubMed ID: 22984865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain.
    Gravenfors Y; Viklund J; Blid J; Ginman T; Karlström S; Kihlström J; Kolmodin K; Lindström J; von Berg S; von Kieseritzky F; Bogar K; Slivo C; Swahn BM; Olsson LL; Johansson P; Eketjäll S; Fälting J; Jeppsson F; Strömberg K; Janson J; Rahm F
    J Med Chem; 2012 Nov; 55(21):9297-311. PubMed ID: 23017051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Wu YJ; Zhang Y; Shi J; Zhai W; Zhu S; Gerritz SW; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Good AC; Grace JE; Lentz KA; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5040-7. PubMed ID: 26497283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency.
    Edwards PD; Albert JS; Sylvester M; Aharony D; Andisik D; Callaghan O; Campbell JB; Carr RA; Chessari G; Congreve M; Frederickson M; Folmer RH; Geschwindner S; Koether G; Kolmodin K; Krumrine J; Mauger RC; Murray CW; Olsson LL; Patel S; Spear N; Tian G
    J Med Chem; 2007 Nov; 50(24):5912-25. PubMed ID: 17985862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl guanidine inhibitors of β-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesis.
    Gerritz SW; Zhai W; Shi S; Zhu S; Toyn JH; Meredith JE; Iben LG; Burton CR; Albright CF; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Metzler W; Cook LS; Padmanabha R; Lentz KA; Sofia MJ; Poss MA; Macor JE; Thompson LA
    J Med Chem; 2012 Nov; 55(21):9208-23. PubMed ID: 23030502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors.
    Brodney MA; Beck EM; Butler CR; Barreiro G; Johnson EF; Riddell D; Parris K; Nolan CE; Fan Y; Atchison K; Gonzales C; Robshaw AE; Doran SD; Bundesmann MW; Buzon L; Dutra J; Henegar K; LaChapelle E; Hou X; Rogers BN; Pandit J; Lira R; Martinez-Alsina L; Mikochik P; Murray JC; Ogilvie K; Price L; Sakya SM; Yu A; Zhang Y; O'Neill BT
    J Med Chem; 2015 Apr; 58(7):3223-52. PubMed ID: 25781223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain.
    Fuchino K; Mitsuoka Y; Masui M; Kurose N; Yoshida S; Komano K; Yamamoto T; Ogawa M; Unemura C; Hosono M; Ito H; Sakaguchi G; Ando S; Ohnishi S; Kido Y; Fukushima T; Miyajima H; Hiroyama S; Koyabu K; Dhuyvetter D; Borghys H; Gijsen HJM; Yamano Y; Iso Y; Kusakabe KI
    J Med Chem; 2018 Jun; 61(12):5122-5137. PubMed ID: 29733614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo.
    Machauer R; Laumen K; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Jaton AL; Desrayaud S; Staufenbiel M; Rabe S; Paganetti P; Neumann U
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1366-70. PubMed ID: 19195887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.
    Baxter EW; Conway KA; Kennis L; Bischoff F; Mercken MH; Winter HL; Reynolds CH; Tounge BA; Luo C; Scott MK; Huang Y; Braeken M; Pieters SM; Berthelot DJ; Masure S; Bruinzeel WD; Jordan AD; Parker MH; Boyd RE; Qu J; Alexander RS; Brenneman DE; Reitz AB
    J Med Chem; 2007 Sep; 50(18):4261-4. PubMed ID: 17685503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency prediction of β-secretase (BACE-1) inhibitors using density functional methods.
    Roos K; Viklund J; Meuller J; Kaspersson K; Svensson M
    J Chem Inf Model; 2014 Mar; 54(3):818-25. PubMed ID: 24456077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
    Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Versatile Approach to CF3 -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors.
    Mateu N; Ciordia M; Delgado O; Sánchez-Roselló M; Trabanco AA; Van Gool M; Tresadern G; Pérez-Benito L; Fustero S
    Chemistry; 2015 Aug; 21(33):11719-26. PubMed ID: 26140617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent and selective BACE-1 inhibitors.
    Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B
    J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and biological evaluation of conformationally constrained BACE1 inhibitors.
    Winneroski LL; Schiffler MA; Erickson JA; May PC; Monk SA; Timm DE; Audia JE; Beck JP; Boggs LN; Borders AR; Boyer RD; Brier RA; Hudziak KJ; Klimkowski VJ; Garcia Losada P; Mathes BM; Stout SL; Watson BM; Mergott DJ
    Bioorg Med Chem; 2015 Jul; 23(13):3260-8. PubMed ID: 26001341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of amidine-based brain penetrant BACE1 inhibitors.
    Oehlrich D; Prokopcova H; Gijsen HJ
    Bioorg Med Chem Lett; 2014 May; 24(9):2033-45. PubMed ID: 24704031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
    Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide derivatives as BACE-1 inhibitors.
    Shangguan S; Wang F; Liao Y; Yu H; Li J; Huang W; Hu H; Yu L; Hu Y; Sheng R
    Molecules; 2013 Mar; 18(3):3577-94. PubMed ID: 23519200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.